Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Mapping of CD8 T Cell Epitopes in Human Respiratory Syncytial Virus L Protein

Texto completo
Autor(es):
Medina-Armenteros, Yordanka [1] ; Farinha-Arcieri, Luis E. [1] ; Braga, Catarina J. M. [1] ; Carromeu, Cassiano [1] ; Tamura, Rodrigo E. [1] ; Ventura, Armando M. [1]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508900 Sao Paulo - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo Científico
Fonte: Intervirology; v. 57, n. 2 2014.
Citações Web of Science: 0
Resumo

Objectives: Since it has been reported that in humans there is a relationship between human respiratory syncytial virus (hRSV)-specific cytotoxic T lymphocytes and symptom reduction, and that the polymerase (structural L protein) is highly conserved among different strains, this work aimed to identify the CD8 T cell epitopes H-2(d) restricted within the L sequence for immunization purposes. Methods: We screened the hRSV strain A2 L protein sequence using two independent algorithms, SYFPEITHI and PRED/(BALB/c), to predict CD8 T cell epitopes. The selected peptides were synthesized and used to immunize BALB/c mice for the evaluation of T cell response. The production of IFN-gamma from splenocytes of hRSV-infected animals stimulated by these peptides was assayed by ELISPOT. Results: Nine peptides showing the best binding scores to the BALB/c MHC-I molecules (H-2K(d), L-d and D-d) were selected. Sequence homology analysis showed that these sequences are conserved among different hRSV strains. Two of these peptides induced significant IFN-gamma production by ex vivo-stimulated T cells. Conclusions: Our results indicate that the hRSV L protein contains H-2(d) restricted epitopes. (C) 2014 S. Karger AG, Basel (AU)

Processo FAPESP: 09/17587-9 - Estudos de imunização e moleculares sobre o Vírus Respiratório Sincicial Humano
Beneficiário:Armando Morais Ventura
Modalidade de apoio: Auxílio à Pesquisa - Regular